Table 3 Serum biomarker group outcomes.
Variable | Metric | NSE group | p-value | S100B group | p-value | ||
|---|---|---|---|---|---|---|---|
Low NSE | High NSE | Low S100B | High s100B | ||||
Length of stay | Median[IQR] | 25.9 [12.5;47.5] | 25.9 [15.3:42,7] | ns | 29.7 [18.8; 52.9] | 19.9 [13.6;28.4] | 0.0017 |
ICU length of stay | Median[IQR] | 21.6 [11.1;42.5] | 25.9 [15.2;39.8] | ns | 28.5 [18.4;50.8] | 19.9 [13.6; 28.5] | 0.0042 |
Death | Yes | 45 (54%) | 55 (74%) | 0.009 | 70 (56%) | 31 (100%) | < 0.001 |
In-hospital death | Yes | 42 (51%) | 56 (76%) | 0.0012 | 71 (56%) | 31 (100%) | < 0.001 |
Days of survival | Median[IQR] | 31.0 [11.0;346.5] | 23.0 [13.2; 42.0] | ns | 32.0 [17.2: 59.5] | 19.0 [11.5; 25.0] | 0.0002 |
